Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study update reporting safety, tolerability, pharmacokinetics and pharmacodynamics of ACZ885 in rheumatoid arthritis patients on methotrexate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ACZ885 (canakinumab)

Snippet

Sponsor: Novartis | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED